The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is seeking public comment on proposals to update the UK’s clinical trial legislation.

No longer part of the European Union, the UK wants to update its clinical trial legislation to improve trials across the board. Specifically, the MHRA aims to streamline its trial approval process, encourage innovation in clinical research, improve the transparency of trials and spur greater patient and public involvement in trials.

The agency is hoping for useful feedback from sponsors, researchers, investigators, trial participants, product manufacturers, healthcare professionals and the general public to give it direction in its trial reforms. The comment period is open until March 14.

Read the full proposals here: https://bit.ly/3gwht0V.